What Is Naproxen?

Naproxen is a nonsteroidal anti-inflammatory drug (NSAID) used for pain, inflammation, and fever. It's available over-the-counter (Aleve) and by prescription. Its longer duration of action means less frequent dosing compared to ibuprofen, making it convenient for chronic pain conditions.1

How It Works2

  • Blocks COX enzymes (COX-1 and COX-2)
  • Reduces prostaglandin production
  • Decreases pain, inflammation, fever
  • Effects last 8-12 hours

Uses

  • Osteoarthritis
  • Rheumatoid arthritis
  • Back pain
  • Menstrual cramps
  • Headaches
  • Tendinitis and bursitis
  • Gout flares

Dosing3

Over-the-Counter (Aleve)

  • 220 mg every 8-12 hours
  • Maximum 660 mg/day (OTC)
  • Take with food or milk

Prescription

  • 250-500 mg twice daily
  • Maximum 1500 mg/day
  • Different formulations available

Common Side Effects

  • Stomach upset, heartburn
  • Nausea
  • Dizziness
  • Drowsiness
  • Headache

Serious Risks

  • GI bleeding and ulcers
  • Cardiovascular events (heart attack, stroke)
  • Kidney problems
  • Allergic reactions
  • Risks increase with duration of use

Who Should Avoid

  • History of GI bleeding or ulcers
  • Cardiovascular disease
  • Kidney disease
  • Aspirin or NSAID allergy
  • Third trimester pregnancy
  • Before coronary artery bypass surgery

Drug Interactions

  • Blood thinners (increased bleeding)
  • Other NSAIDs (don't combine)
  • Blood pressure medications
  • Lithium
  • Diuretics

Safety Tips

  • Take with food
  • Use lowest effective dose
  • Limit duration when possible
  • Stay hydrated
  • Watch for warning signs
  • Regular doctor monitoring for chronic use

References

  1. Coxib and traditional NSAID Trialists' (CNT) Collaboration. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs. Lancet. 2013;382(9894):769-779.
  2. Sostres C, Gargallo CJ, Arroyo MT, Lanas A. Adverse effects of non-steroidal anti-inflammatory drugs. Dig Liver Dis. 2010;42(12):818-826.
  3. Bauer AW. Naproxen. In: StatPearls. StatPearls Publishing; 2023.